S-1/A: Abacus Life Files Amendment for Common Stock Offering

Abacus Life updates its registration statement for a common stock offering in response to SEC comments.

Summary

• Abacus Life, Inc. filed an amendment to its Form S-1 registration statement with the SEC on May 30, 2024.
• The filing relates to a proposed offering of the company's common stock.
• The amendment addresses comments received from the SEC regarding the initial registration statement.
• The company plans to use the net proceeds from the offering for general corporate purposes, including the purchase of life settlement policies and working capital.
• The common stock is listed on The Nasdaq Capital Market under the symbol ABL.

Sentiment

Score: 5

Explanation: The document presents a mix of positive and negative aspects. While it highlights the company's growth and market position, it also outlines significant risks and uncertainties, resulting in a neutral sentiment.

Positives

• The company has a proven track record of growth and strong asset returns.
• Abacus is operational in 49 states, which is a key differentiator in an industry with high barriers to entry.
• The company has a seasoned management team with an average of over 20 years of experience in the industry.

Risks

• The company's valuation of life insurance policies is uncertain, and erroneous valuations could have a material adverse impact.
• Failure to accurately forecast life expectancies could result in lower returns on life settlement policies.
• Increased competition from originating life insurance companies, life insurance brokers, and investment funds could have a material adverse effect.
• The company's revenue is concentrated in a limited number of customers, some of which are related parties.
• Negative public perception of the life settlement industry could affect the value and/or liquidity of the company's investments.
• There is a risk of fraud in the origination of the original life insurance policy or in subsequent sales of the life insurance policy.
• The company may become subject to claims by life insurance companies, individuals and their families, or regulatory authorities.
• Life settlements in which the company invests are not currently regulated under federal securities laws, but if deemed to be securities, it would require further compliance.
• The company faces privacy and cybersecurity risks related to its maintenance of proprietary information.
• The company is subject to U.S. privacy laws and regulations, and failure to comply could lead to regulatory investigations or actions.
• The failure of the company to accurately and timely track and pay premium payments on the life insurance policies it holds could result in the lapse of such policies.
• The originating life insurance company may increase the cost of insurance premiums, which would adversely affect the company's returns.
• The company may not be able to liquidate its life insurance policies, which could have a material adverse effect on the company's business.
• The company assumes the credit risk associated with life insurance companies and may not be able to realize the full value of insurance company payouts.
• The company's success is dependent upon the services of its experienced management and talented employees.
• The company's intellectual property rights may not adequately protect the company's business.
• The company may become subject to intellectual property disputes, which are costly and may subject the company to significant liability and increased costs of doing business.
• The company has identified material weaknesses in its internal control over financial reporting that existed as of December 31, 2022, which were remediated as of December 31, 2023.
• The company's management has limited experience in operating a public company.
• The company's indebtedness may restrict its operations.
• If the company is unable to comply with its debt agreements, or to raise additional capital when needed, its business, cash flow, liquidity, and results of operations could be harmed.
• The company may incur substantially more debt, which could exacerbate further the risks associated with its leverage.

Future Outlook

The company intends to use the net proceeds from the offering for operations, including the purchase of life settlement policies, supporting its overall business strategy, working capital purposes and general corporate purposes, which may include repayment and refinancing of its indebtedness.

Industry Context

Abacus Life operates in the life settlements industry, which involves the purchase and sale of existing life insurance policies. The industry is subject to regulatory oversight and faces competition from other life settlement providers and insurance companies.

Comparison to Industry Standards

• The company has approximately a 20% market share based on its 2022 capital invested/total industry capital invested and data compiled in a 2022 report by The Deal and Life Settlements Report.
• This positions Abacus Life as a leader in the life settlements industry, competing with other major players in the market.
• The company's ability to operate in 49 states is a key differentiator, as it demonstrates a strong ability to navigate the complex regulatory landscape of the life settlement market.

Related Party Transactions

• One financing entity, a company in which Abacus Settlements members own interests, represented 23% and 60% of Abacus Settlements revenues in six months ended June 30, 2023 and year ended December 31, 2022, respectively.
• Additionally, two brokers represented the sellers for over 10% of Abacus Settlements life settlement commission expense during the period six months ended June 30, 2023.
• For the year ended December 31, 2023, two related party customers accounted for 59% and 33% of the total balance of related party receivables, and three customers accounted for 49%, 14%, and 12%, of Active management revenue of the Company, respectively.

Stakeholder Impact

• Shareholders will experience dilution as a result of the new share issuance.
• The company's employees may benefit from the increased financial stability and growth opportunities resulting from the offering.
• Customers may benefit from the company's ability to invest in its services and expand its operations.

Next Steps

• The company will proceed with the proposed offering of common stock.
• The underwriters will market and sell the shares to the public.
• The company will use the net proceeds for its stated purposes.

Key Dates

Keywords

life settlements, common stock, offering, registration statement, Abacus Life, securities, prospectus, underwriting, financial, insurance